Terms: = Thyroid cancer AND PDCD1LG2, Q9BQ51, 80380, ENSG00000197646, MGC142240, Btdc, PDCD1L2, CD273, B7DC, MGC142238, PD-L2, PDL2, bA574F11_2 AND Prognosis
2510 results:
1. Lateral lymph node metastasis in papillary thyroid cancer: Is there a difference between PTC and PTMC?
Ma W; Guo Y; Hua T; Li L; Lv T; Wang J
Medicine (Baltimore); 2024 Apr; 103(17):e37734. PubMed ID: 38669400
[TBL] [Abstract] [Full Text] [Related]
2. CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
Shen J; Ma Z; Yang J; Qu T; Xia Y; Xu Y; Zhou M; Liu W
BMC Cancer; 2024 Apr; 24(1):511. PubMed ID: 38654205
[TBL] [Abstract] [Full Text] [Related]
3. Clinical value of KiSS-1 and MMP-2 expression levels in breast cancer tissue in evaluating prognosis of elderly breast cancer patients after modified radical mastectomy.
Lv J; Zhang J; Wu F
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):254-259. PubMed ID: 38650158
[TBL] [Abstract] [Full Text] [Related]
4. Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma.
Fang Q; Yuan J; Zhang X; Dai L; Luo R; Xu C
Oral Oncol; 2024 May; 152():106810. PubMed ID: 38631065
[TBL] [Abstract] [Full Text] [Related]
5. Genetic alterations and allele frequency of BRAF V600E and TERT mutation in papillary thyroid carcinoma with intermediate-to-high recurrence risk: a retrospective study.
Huang J; Wang J; Xv J; Wang J; Wang G; Zhao Y
Clin Exp Med; 2024 Apr; 24(1):76. PubMed ID: 38607456
[TBL] [Abstract] [Full Text] [Related]
6. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
Wang H; Zhang C; Li Q; Tian T; Huang R; Qiu J; Tian R
BMC Cancer; 2024 Apr; 24(1):427. PubMed ID: 38589799
[TBL] [Abstract] [Full Text] [Related]
7. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract] [Full Text] [Related]
8. BRAF
Zhao H; Liu CH; Lu Y; Liu SZ; Yeerkenbieke P; Cao Y; Xia Y; Gao LY; Liu YW; Liu ZW; Chen SG; Liang ZY; Li XY
Oral Oncol; 2024 May; 152():106755. PubMed ID: 38547780
[TBL] [Abstract] [Full Text] [Related]
9. Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated thyroid Carcinomas.
Matos ML; Pinto M; Alves M; Canberk S; Gonçalves A; Bugalho MJ; Papoila AL; Soares P
Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540448
[TBL] [Abstract] [Full Text] [Related]
10. Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M; Zhang X; Ming Z; Lingyu ; Feng X; Han Z; An HX
J Transl Med; 2024 Mar; 22(1):315. PubMed ID: 38539235
[TBL] [Abstract] [Full Text] [Related]
11. DNA Methylation-Regulated HOXC8's Role in HER2-Positive Breast cancer Function and its Contribution to Herceptin Resistance.
Xie X; Tang S; Yu Z
Discov Med; 2024 Mar; 36(182):559-570. PubMed ID: 38531796
[TBL] [Abstract] [Full Text] [Related]
12. "Examining the link between tooth agenesis and papillary thyroid cancer: is there a risk factor?" Observational study.
Matošić Ž; Šimunović L; Jukić T; Granić R; Meštrović S
Prog Orthod; 2024 Mar; 25(1):12. PubMed ID: 38523193
[TBL] [Abstract] [Full Text] [Related]
13. Endoscopic mastectomy followed by immediate breast reconstruction with fat grafting for breast cancer.
Narui K; Satake T; Ishikawa T; Muto M; Tsunoda Y; Yamada A; Kawashima K; Uenaka N; Fujiwara Y; Oshi M; Adachi S; Suzuki C; Wada T; Yamamoto S; Tanabe M; Maegawa J; Endo I
Breast Cancer; 2024 May; 31(3):476-484. PubMed ID: 38512534
[TBL] [Abstract] [Full Text] [Related]
14. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
[TBL] [Abstract] [Full Text] [Related]
15. Clinicopathological features and prognostic value of CD276 expression in female reproductive system malignancies: A meta-analysis.
Su H; Hao JJ; Xu YB; Zhang FH
Taiwan J Obstet Gynecol; 2024 Mar; 63(2):154-160. PubMed ID: 38485307
[TBL] [Abstract] [Full Text] [Related]
16. Nitric oxide nano-reactor DNMF/PLGA enables tumor vascular microenvironment and chemo-hyperthermia synergetic therapy.
Wang R; Cheng L; He L; Du C; Wang H; Peng B; Yu X; Liu W; Luo W; Ran H; Yang L
J Nanobiotechnology; 2024 Mar; 22(1):110. PubMed ID: 38481281
[TBL] [Abstract] [Full Text] [Related]
17. The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis.
Zhang H; Tian L; Wang X; Shi X
Front Endocrinol (Lausanne); 2024; 15():1349041. PubMed ID: 38476675
[TBL] [Abstract] [Full Text] [Related]
18. [Importance of Secondary cancer Screening-In the Case of Childhood cancer].
Ishida Y
Gan To Kagaku Ryoho; 2024 Feb; 51(2):119-124. PubMed ID: 38449394
[TBL] [Abstract] [Full Text] [Related]
19. PLK4 reflects extrathyroidal invasion, high tumor stage and poor prognosis in papillary thyroid carcinoma patients.
Hu X; Yu J; Chen M; Pang R
Biomark Med; 2024 Mar; 18(5):169-179. PubMed ID: 38440866
[No Abstract] [Full Text] [Related]
20. Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment.
Yan K; Liu QZ; Huang RR; Jiang YH; Bian ZH; Li SJ; Li L; Shen F; Tsuneyama K; Zhang QL; Lian ZX; Guan H; Xu B
Clin Transl Med; 2024 Mar; 14(3):e1594. PubMed ID: 38426403
[TBL] [Abstract] [Full Text] [Related]
[Next]
